Aion Therapeutic Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Stock Symbol
  • ANTCF

Stock Symbol

  • Investments
  • 2

Aion Therapeutic General Information

Description

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.

Contact Information

Formerly Known As
Osoyoos Cannabis
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 45 Sheppard Avenue East
  • Suite 703
  • Toronto, Ontario M2N 5W9
  • Canada
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 45 Sheppard Avenue East
  • Suite 703
  • Toronto, Ontario M2N 5W9
  • Canada

Aion Therapeutic Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aion Therapeutic Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
21.3K -$0.01

Aion Therapeutic Financials Summary

As of 31-Jan-2025, Aion Therapeutic has a trailing 12-month revenue of $1.07M.

In Thousands,
USD
TTM 31-Jan-2025 FY 2024 30-Apr-2024 FY 2023 30-Apr-2023 FY 2022 30-Apr-2022
EV 5,091 7,280 1,784 2,718
Revenue 1,067 272 0 0
EBITDA (4,489) (4,508) (67) (2,930)
Net Income (4,815) (4,655) (193) (3,042)
Total Assets 832 514 154 116
Total Debt 1,938 1,523 710 523
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aion Therapeutic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aion Therapeutic‘s full profile, request access.

Request a free trial

Aion Therapeutic Patents

Aion Therapeutic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022165439-A1 Methods for treatment of human cancers using cannabis compositions Inactive 01-Feb-2021

Aion Therapeutic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aion Therapeutic‘s full profile, request access.

Request a free trial

Aion Therapeutic Acquisitions (2)

Aion Therapeutic’s most recent deal was a Merger/Acquisition with Toppen Health for . The deal was made on 15-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Toppen Health 15-Dec-2023 Merger/Acquisition Specialty Chemicals
AI Pharmaceuticals Jamaica 30-Jun-2020 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Aion Therapeutic’s complete acquisitions history, request access »

Aion Therapeutic ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Services

Subindustry

Rank

Percentile

To view Aion Therapeutic’s complete esg history, request access »

Aion Therapeutic FAQs

  • When was Aion Therapeutic founded?

    Aion Therapeutic was founded in 2011.

  • Where is Aion Therapeutic headquartered?

    Aion Therapeutic is headquartered in Toronto, Canada.

  • What industry is Aion Therapeutic in?

    Aion Therapeutic’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Aion Therapeutic a private or public company?

    Aion Therapeutic is a Public company.

  • What is Aion Therapeutic’s stock symbol?

    The ticker symbol for Aion Therapeutic is ANTCF.

  • What is Aion Therapeutic’s current revenue?

    The trailing twelve month revenue for Aion Therapeutic is $1.07M.

  • What is Aion Therapeutic’s annual earnings per share (EPS)?

    Aion Therapeutic’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process